Ausgabe 4/2018
Inhalt (11 Artikel)
Chronische Hypoxie und kardiovaskuläres Risiko
U. Koehler, O. Hildebrandt, J. Krönig, W. Grimm, J. Otto, W. Hildebrandt, R. Kinscherf
Telemonitoring bei Herzinsuffizienz
L. Diedrich, C. Dockweiler, A. Kupitz, C. Hornberg
Efficacy of RADPAD protective drape during coronary angiography
B. Kherad, T. Jerichow, F. Blaschke, M. Noutsias, B. Pieske, C. Tschöpe, F. Krackhardt
Prognosis of patients with implanted pacemakers in 4‑year follow-up
K. Krzemień-Wolska, A. Tomasik, E. Nowalany-Kozielska, W. Jacheć
Transcatheter vs. surgical aortic valve replacement and medical treatment
A. Ak, I. Porokhovnikov, F. Kuethe, P. C. Schulze, M. Noutsias, P. Schlattmann
Use of tolvaptan vs. furosemide in older patients with heart failure
W.‑l. Huang, Y. Yang, J. Yang, J. Yang, H.‑b. Wang, X.‑l. Xiong, Y.‑f. Zhang
Cerebral dopamine neurotrophic factor protects H9c2 cardiomyocytes from apoptosis
H. Liu, C. Yu, H. Yu, L. Zhong, Y. Wang, J. Liu, S. Zhang, J. Sun, L. Duan, L. Gong, J. Yang
European guidelines on lifestyle changes for management of hypertension
J. Bolbrinker, L. Zaidi Touis, H. Gohlke, B. Weisser, R. Kreutz
Serum endocan levels in patients with cardiac syndrome X
S. C. Efe, K. Demirci, S. Ozturk, A. S. Gurbuz, N. Poci, A. Kilicgedik, A. Guler, M. F. Yilmaz, İ. A. İzgi, C. Kirma